CompaniesByCap
MRNA
Moderna, Inc. (MRNA)
NASDAQ · Healthcare

Moderna, Inc. Revenue 2016–2025

Moderna, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Moderna, Inc. revenue for the quarter ending March 31, 2026 was 389.0 M, a 260.19% increase year-over-year.
  • Moderna, Inc. revenue for the twelve months ending March 31, 2026 was 1.7 B, a 59.64% decrease year-over-year.
  • Moderna, Inc. annual revenue for 2025 was 1.9 B, a 39.93% decrease from 2024.
  • Moderna, Inc. annual revenue for 2024 was 3.2 B, a 52.75% decrease from 2023.
  • Moderna, Inc. annual revenue for 2023 was 6.8 B, a 64.45% decrease from 2022.
  • Moderna, Inc. annual revenue for 2022 was 19.3 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Moderna Inc. Market Cap — FAQ

Moderna Inc. (MRNA) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MRNA's market cap history?

The chart and table above show Moderna Inc.'s market cap by year and by quarter, including the growth rate.